Russell Pachynski

19PUBLICATIONS

234CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targetsRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jul 10, 2026

Automating neoantigen selection for personalized cancer vaccine design.

|May 07, 2026

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Apr 24, 2026

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).

|Apr 17, 2026

Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

|Apr 17, 2026

AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC.

|Dec 08, 2025

Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer.

Kavita Rawat, Varnika Punia, Parker Mathews

Pageof 4

Frequent Collaborators

Melissa A Reimers

Aadel A Chaudhuri

Daniel P Petrylak

Pradeep S Chauhan

Douglas G McNeel

Todd A Fehniger

Evan Y Yu

Christopher A Maher

James L Gulley

Karim Fizazi

Frequent Collaborators

Melissa A Reimers

Aadel A Chaudhuri

Daniel P Petrylak

Pradeep S Chauhan